Renhe Pharmacy Co Ltd (000650) - Total Assets

Latest as of September 2025: CN¥8.10 Billion CNY ≈ $1.19 Billion USD

Based on the latest financial reports, Renhe Pharmacy Co Ltd (000650) holds total assets worth CN¥8.10 Billion CNY (≈ $1.19 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Renhe Pharmacy Co Ltd shareholders equity for net asset value and shareholders' equity analysis.

Renhe Pharmacy Co Ltd - Total Assets Trend (1993–2024)

This chart illustrates how Renhe Pharmacy Co Ltd's total assets have evolved over time, based on quarterly financial data.

Renhe Pharmacy Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Renhe Pharmacy Co Ltd's total assets of CN¥8.10 Billion consist of 64.4% current assets and 35.6% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 31.1%
Accounts Receivable CN¥472.62 Million 6.3%
Inventory CN¥486.94 Million 6.5%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥318.72 Million 4.3%
Goodwill CN¥501.91 Million 6.7%

Asset Composition Trend (1993–2024)

This chart illustrates how Renhe Pharmacy Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Renhe Pharmacy Co Ltd (000650) market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Renhe Pharmacy Co Ltd's current assets represent 64.4% of total assets in 2024, an increase from 26.0% in 1993.
  • Cash Position: Cash and equivalents constituted 31.1% of total assets in 2024, up from 2.3% in 1993.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 0.0% in 1993.
  • Asset Diversification: The largest asset category is goodwill at 6.7% of total assets.

Renhe Pharmacy Co Ltd Competitors by Total Assets

Key competitors of Renhe Pharmacy Co Ltd based on total assets are shown below.

Company Country Total Assets
Changchun High & New Technology Industries Group Inc
SHE:000661
China CN¥31.46 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Tasly Pharmaceutical Group Co Ltd
SHG:600535
China CN¥15.34 Billion
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
China CN¥15.32 Billion
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
China CN¥10.96 Billion
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
China CN¥1.54 Billion
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
China CN¥6.74 Billion
Cronos Group Inc
TO:CRON
Canada CA$1.18 Billion

Renhe Pharmacy Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 5.10 6.20 5.60
Quick Ratio 4.71 5.70 4.94
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥4.20 Billion CN¥3.90 Billion CN¥3.15 Billion

Renhe Pharmacy Co Ltd - Advanced Valuation Insights

This section examines the relationship between Renhe Pharmacy Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.29
Latest Market Cap to Assets Ratio 0.16
Asset Growth Rate (YoY) 0.5%
Total Assets CN¥7.48 Billion
Market Capitalization $1.17 Billion USD

Valuation Analysis

Below Book Valuation: The market values Renhe Pharmacy Co Ltd's assets below their book value (0.16x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Renhe Pharmacy Co Ltd's assets grew by 0.5% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Renhe Pharmacy Co Ltd (1993–2024)

The table below shows the annual total assets of Renhe Pharmacy Co Ltd from 1993 to 2024.

Year Total Assets Change
2024-12-31 CN¥7.48 Billion
≈ $1.09 Billion
+0.51%
2023-12-31 CN¥7.44 Billion
≈ $1.09 Billion
-2.45%
2022-12-31 CN¥7.63 Billion
≈ $1.12 Billion
+10.48%
2021-12-31 CN¥6.91 Billion
≈ $1.01 Billion
+9.56%
2020-12-31 CN¥6.31 Billion
≈ $922.63 Million
+26.50%
2019-12-31 CN¥4.98 Billion
≈ $729.38 Million
+7.97%
2018-12-31 CN¥4.62 Billion
≈ $675.56 Million
+10.78%
2017-12-31 CN¥4.17 Billion
≈ $609.82 Million
+7.83%
2016-12-31 CN¥3.86 Billion
≈ $565.56 Million
+22.45%
2015-12-31 CN¥3.16 Billion
≈ $461.86 Million
+21.53%
2014-12-31 CN¥2.60 Billion
≈ $380.04 Million
+11.53%
2013-12-31 CN¥2.33 Billion
≈ $340.76 Million
+11.16%
2012-12-31 CN¥2.09 Billion
≈ $306.54 Million
+30.70%
2011-12-31 CN¥1.60 Billion
≈ $234.54 Million
+8.43%
2010-12-31 CN¥1.48 Billion
≈ $216.30 Million
+39.34%
2009-12-31 CN¥1.06 Billion
≈ $155.24 Million
+142.32%
2008-12-31 CN¥437.80 Million
≈ $64.06 Million
+41.92%
2007-12-31 CN¥308.48 Million
≈ $45.14 Million
+13.53%
2006-12-31 CN¥271.72 Million
≈ $39.76 Million
-40.41%
2005-12-31 CN¥456.00 Million
≈ $66.73 Million
-24.09%
2004-12-31 CN¥600.73 Million
≈ $87.91 Million
-11.58%
2003-12-31 CN¥679.38 Million
≈ $99.41 Million
-10.57%
2002-12-31 CN¥759.66 Million
≈ $111.16 Million
+6.70%
2001-12-31 CN¥711.94 Million
≈ $104.18 Million
+9.26%
2000-12-31 CN¥651.61 Million
≈ $95.35 Million
+36.83%
1999-12-31 CN¥476.21 Million
≈ $69.69 Million
+32.26%
1998-12-31 CN¥360.06 Million
≈ $52.69 Million
+29.43%
1997-12-31 CN¥278.20 Million
≈ $40.71 Million
+3.14%
1996-12-31 CN¥269.74 Million
≈ $39.47 Million
+57.91%
1995-12-31 CN¥170.81 Million
≈ $25.00 Million
-1.11%
1994-12-31 CN¥172.73 Million
≈ $25.28 Million
+33.22%
1993-12-31 CN¥129.66 Million
≈ $18.97 Million
--

About Renhe Pharmacy Co Ltd

SHE:000650 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.17 Billion
CN¥7.97 Billion CNY
Market Cap Rank
#8451 Global
#2182 in China
Share Price
CN¥5.69
Change (1 day)
-0.18%
52-Week Range
CN¥5.34 - CN¥7.02
All Time High
CN¥11.50
About

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in … Read more